The rare disease community has received increased public attention as Chinese authorities has issued a circular on further promoting the prevention and control measures, while strengthening the supportive care needs of patients with rare diseases. Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950), China Alliance for Rare Diseases, RDPAC, China Pharmaceutical Innovation and Research Development Association, China National Pharmaceutical Industry Information Center, domestic and international enterprises jointly announced the proposal of“Caring for Rare Disease Community and Achieving Social Harmony” during the 2022 China Conference on Rare Diseases held on 29 October 2022.
English 
Thai